Cargando…
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
Objective: Ovarian cancer is a leading cause of death from gynecological cancers. Late diagnosis and resistance to therapy results in mortality and effective screening is required for early diagnosis and better treatments. Expression of the Fanconi Anemia complementation group D2 protein (FANCD2) is...
Autores principales: | Joshi, Sonali, Campbell, Shawn, Lim, Jeong Y., McWeeney, Shannon, Krieg, Adam, Bean, Yukie, Pejovic, Nadja, Mhawech-Fauceglia, Paulette, Pejovic, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055545/ https://www.ncbi.nlm.nih.gov/pubmed/32165999 http://dx.doi.org/10.18632/oncotarget.27437 |
Ejemplares similares
-
MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012) -
The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers
por: Vermehren-Schmaedick, Anke, et al.
Publicado: (2020) -
Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
por: Batman, Samantha, et al.
Publicado: (2021) -
Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012) -
BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
por: Wysham, Weiya Z., et al.
Publicado: (2012)